IL1B and atherosclerosis: These studies suggest that the contribution of CH clones to atherosclerosis development could result from a myeloid bias in which mutated HSCs produce increased quantities of monocytes and macrophages that promote IL-1, IL-6, and TNF production and drive systemic and vascular inflammation (9, 10).